recombinant human interleukin-18 (Beijing SL Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant human interleukin-18 (Beijing SL Pharmaceutical)
Drug Alias NamerhIL-18 (Beijing SL Pharmaceutical)Recombinant Human IL-18 (Beijing SL Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin 18 stimulants
TargetsInterleukin 18
Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sl Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasmsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A